ARTICLE SYNOPSIS...Has Avigen peaked? The stock gained after an advisory committee of the U.S. National Institute of Health stated it would recommend the initiation of human clinical trials for Avigen's AV201, a gene therapy for advanced Parkinson's disease.
ARTICLE SYNOPSIS...By forming a bullish wedge, the biotechnology index gets ready to continue the bull run.
ARTICLE SYNOPSIS...The pullback rally has turned sideways in between the two Fibonacci retracements levels for the biotech index. This support-resistance area is also intercepted by the moving average hurdle.
ARTICLE SYNOPSIS...Will the index plunge to its lowest support?
ARTICLE SYNOPSIS...There is a strong bull market in effect so it's important to single out the stock leaders who offer a combination of strength and forward-looking growth.
ARTICLE SYNOPSIS...Investment in a company of hope or pure Las Vegas speculation?
ARTICLE SYNOPSIS...The lower highs in price and the long-term moving average upside move formed a symmetrical triangle. The breakdown has forced the index to plunge. Will the freefall continue?